Original Research

Price, availability and affordability of medicines

Brenda S. Mhlanga, Fatima Suleman
African Journal of Primary Health Care & Family Medicine | Vol 6, No 1 | a604 | DOI: https://doi.org/10.4102/phcfm.v6i1.604 | © 2014 Brenda S. Mhlanga, Fatima Suleman | This work is licensed under CC Attribution 4.0
Submitted: 08 October 2013 | Published: 24 June 2014

About the author(s)

Brenda S. Mhlanga, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, South Africa
Fatima Suleman, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, South Africa

Abstract

Background: Medicines play an important role in healthcare, but prices can be a barrier to patient care. Few studies have looked at the prices of essential medicines in low- and middle-income countries in terms of patient affordability.

Aim: To determine the prices, availability and affordability of medicines along the supply chain in Swaziland.

Setting: Private- and public-sector facilities in Manzini, Swaziland.

Methods: The standardised methodology designed by the World Health Organization and Health Action International was used to survey 16 chronic disease medicines. Data were collected in one administrative area in 10 private retail pharmacies and 10 public health facilities. Originator brand (OB) and lowest-priced generic equivalent (LPG) medicines were monitored and these prices were then compared with international reference prices (IRPs). Affordability was calculated in terms of the daily wage of the lowest-paid unskilled government worker.

Results: Mean availability was 68% in the public sector. Private sector OB medicines were priced 32.4 times higher than IRPs, whilst LPGs were 7.32 times higher. OBs cost473% more than LPGs. The total cumulative mark-ups for individual medicines range from 190.99% – 440.27%. The largest contributor to add-on cost was the retail mark-up (31% – 53%). Standard treatment with originator brands cost more than a day’s wage.

Conclusion: Various policy measures such as introducing price capping at all levels of the medicine supply chain, may increase the availability, whilst at the same time reducing the prices of essential medicines for the low income population.


Keywords

Availability, affordability, chronic disease, access to medicine, pricing policy

Metrics

Total abstract views: 8187
Total article views: 12942

 

Crossref Citations

1. Perception toward generic drug products: A cross-sectional study among undergraduate pharmacy students of the University of Nigeria
Anosike Chibueze, Isah Abdulmuminu, Isiogugu Nnanyelugo Ogechukwu, Ekwuofu Amos Azubuike
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector  vol: 14  issue: 3  first page: 109  year: 2018  
doi: 10.1177/1741134318785206

2. An imprecise probability approach-based determination of over-represented southern African plant genera and families used in ethnopharmacology
Prince N. Moyo, Fanie R. van Heerden
Journal of Ethnopharmacology  vol: 324  first page: 117757  year: 2024  
doi: 10.1016/j.jep.2024.117757

3. Availability of medical schemes’ formulary medicines in community pharmacies in Durban, South Africa
Bernita Haripersad, Neelaveni Padayachee, Varsha Bangalee
Journal of Pharmaceutical Health Services Research  vol: 13  issue: 2  first page: 95  year: 2022  
doi: 10.1093/jphsr/rmac013

4. Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023
Amirmohammad Tajik, Mehdi Varmaghani, Vahid Ghavami, Nasrin Saeedi, Farshad Sharifi, Alireza Khajavi, Laleh Satarzadeh
Journal of Diabetes & Metabolic Disorders  vol: 23  issue: 2  first page: 1929  year: 2024  
doi: 10.1007/s40200-024-01444-0

5. The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa
Irene Akua Agyepong, Nelson Sewankambo, Agnes Binagwaho, Awa Marie Coll-Seck, Tumani Corrah, Alex Ezeh, Abebaw Fekadu, Nduku Kilonzo, Peter Lamptey, Felix Masiye, Bongani Mayosi, Souleymane Mboup, Jean-Jacques Muyembe, Muhammad Pate, Myriam Sidibe, Bright Simons, Sheila Tlou, Adrian Gheorghe, Helena Legido-Quigley, Joanne McManus, Edmond Ng, Maureen O'Leary, Jamie Enoch, Nicholas Kassebaum, Peter Piot
The Lancet  vol: 390  issue: 10114  first page: 2803  year: 2017  
doi: 10.1016/S0140-6736(17)31509-X

6. Availability, price, and affordability of WHO priority maternal and child health medicine in public health facilities of Dessie, north-East Ethiopia
Abel Demerew Hailu, Solomon Ahmed Mohammed
BMC Medical Informatics and Decision Making  vol: 20  issue: 1  year: 2020  
doi: 10.1186/s12911-020-01247-2

7. The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses
Keiko Marshall, Philippa Beaden, Hammad Durrani, Kun Tang, Roman Mogilevskii, Zulfiqar Bhutta
International Journal of Qualitative Studies on Health and Well-being  vol: 18  issue: 1  year: 2023  
doi: 10.1080/17482631.2022.2156099

8. Affordability of commonly prescribed antibiotics in a large tertiary teaching hospital in Ethiopia: a challenge for the national drug policy objective
Girma Gutema, Ephrem Engidawork
BMC Research Notes  vol: 11  issue: 1  year: 2018  
doi: 10.1186/s13104-018-4021-2

9. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan
Murad Bibi, Noman Ul Haq, Abdul Kareem, Habib Ullah, Nizam Baloch, Gulalai Rehman, Aqeel Nasim
International Journal of Public Health  vol: 67  year: 2022  
doi: 10.3389/ijph.2022.1604375

10. Primary health care roles of community pharmacists in low- and middle-income countries: a mixed methods systematic review
Erick Wesley Hedima, Roland Nnaemeka Okoro
BMC Health Services Research  vol: 25  issue: 1  year: 2025  
doi: 10.1186/s12913-025-13387-0

11. Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
Kah Seng Lee, Yaman Walid Kassab, Nur Akmar Taha, Zainol Akbar Zainal
Pharmacy  vol: 9  issue: 1  first page: 1  year: 2020  
doi: 10.3390/pharmacy9010001

12. Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
Denis Kibira, Freddy Eric Kitutu, Gemma Buckland Merrett, Aukje K. Mantel-Teeuwisse
Journal of Pharmaceutical Policy and Practice  vol: 10  issue: 1  year: 2017  
doi: 10.1186/s40545-017-0123-9

13. WHO key access antibiotics prices, availability and affordability in private sector pharmacies in Pakistan
Zikria Saleem, Hamid Saeed, Zunaira Akbar, Amna Saeed, Saleha Khalid, Laiba Farrukh, Aleena Irfan, Azka Anam, Mohamed Azmi Hassali, Huma Rasheed, Zaheer-Ud-Din Babar
Cost Effectiveness and Resource Allocation  vol: 19  issue: 1  year: 2021  
doi: 10.1186/s12962-021-00263-x

14. Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa
Davis Kibirige, Ronald Olum, Andrew Peter Kyazze, Felix Bongomin, Richard E. Sanya
Tropical Medicine & International Health  vol: 27  issue: 11  first page: 942  year: 2022  
doi: 10.1111/tmi.13819

15. Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020
Fatemeh Kokabisaghi, Amir Hashemi-Meshkini, Asaad Obewal, Vahid Ghavami, Javad Javan-Noughabi, Hamidreza Shabanikiya, Mehdi Varmaghani, Javad Moghri
DARU Journal of Pharmaceutical Sciences  vol: 30  issue: 2  first page: 343  year: 2022  
doi: 10.1007/s40199-022-00454-8

16. A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain
Iris R. Joosse, David Tordrup, Julie Glanville, Aukje K. Mantel-Teeuwisse, Hendrika A. van den Ham
Health Policy  vol: 138  first page: 104919  year: 2023  
doi: 10.1016/j.healthpol.2023.104919

17. Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia
Hachalu Dugasa Deressa, Habtamu Abuye, Alemayehu Adinew, Mohammed K. Ali, Tedla Kebede, Bruck Messele Habte
Global Health Research and Policy  vol: 9  issue: 1  year: 2024  
doi: 10.1186/s41256-024-00352-3

18. Formulation and Cost-Effectiveness of Fluid Gels as an Age-Appropriate Dosage Form for Older Adults with Dysphagia
Zul Hadif Abd Aziz, Haliza Katas, Marhanis Salihah Omar, Noraida Mohamed Shah, Salma Mohamad Yusop
Dysphagia  vol: 37  issue: 4  first page: 1022  year: 2022  
doi: 10.1007/s00455-021-10365-6

19. Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya
Dennis Ongarora, Jamlick Karumbi, Warnyta Minnaard, Kennedy Abuga, Vincent Okungu, Isaac Kibwage
Pharmacy  vol: 7  issue: 2  first page: 40  year: 2019  
doi: 10.3390/pharmacy7020040

20. Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future
Brian Godman, Debashis Basu, Yogan Pillay, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D. Anand Paramadhas, Celda Tiroyakgosi, Patrick Mbah Okwen, Loveline Lum Niba, Justice Nonvignon, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Larry A. Distiller, Enos M. Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A. Amu, Zinhle Matsebula, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C. Meyer
Frontiers in Pharmacology  vol: 11  year: 2020  
doi: 10.3389/fphar.2020.00108

21. Availability, affordability, and quality of essential anti‐seizure medication in Cambodia
Noudy Sengxeu, Chanraksmey Aon, Hanh Dufat, Farid Boumediene, Samleng Chan, Sina Ros, Pierre‐Marie Preux, Voa Ratsimbazafy, Jeremy Jost
Epilepsia Open  vol: 6  issue: 3  first page: 548  year: 2021  
doi: 10.1002/epi4.12514

22. Green supply chain coordination with profit-sharing and government intervention: a game-theoretic approach applied to the pharmaceutical industry
Milad Darzi Ramandi, Armin Jabbarzadeh, Amin Chaabane, Lionel Amodeo
Journal of the Operational Research Society  first page: 1  year: 2025  
doi: 10.1080/01605682.2025.2544865

23. Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines
Leila Zarei, Iman Karimzadeh, Najmeh Moradi, Payam Peymani, Sara Asadi, Zaheer-Ud-Din Babar
International Journal of Environmental Research and Public Health  vol: 17  issue: 5  first page: 1710  year: 2020  
doi: 10.3390/ijerph17051710

24. Commodity security frameworks for health planning
Ebenezer Kwabena Tetteh
Exploratory Research in Clinical and Social Pharmacy  vol: 2  first page: 100025  year: 2021  
doi: 10.1016/j.rcsop.2021.100025

25. POSSIBLE SOLUTION FOR THE GLOBAL PROBLEM OF THE HIGH COST OF MEDICINES
Petro Oliinyk, Bohdan Hromovyk, Taras Gutor, Roman Roman, Serhii Oliinyk, Anna Rybachuk, Ostap Pankevych, Natalia Zaremba
Proceeding of the Shevchenko Scientific Society. Medical Sciences  vol: 73  issue: 1  year: 2024  
doi: 10.25040/ntsh2024.01.01